ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 324

Measurement and Evaluation of Isotypes of Anti-Citrullinated Fibrinogen and Anti-Citrullinated Alpha-Enolase Antibodies in Juvenile Idiopathic Arthritis Patients

Brooke Gilliam1, Sandra Crespo-Pagnussat2, Anil K. Chauhan2 and Terry L. Moore3, 1IM-Rheumatology, Saint Louis University, St. Louis, MO, 2Rheumatology, Saint Louis University, St. Louis, MO, 3Internal Medicine/Rheumatology, Saint Louis University, Saint Louis, MO

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Anti-CCP antibodies and juvenile idiopathic arthritis (JIA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Anti-cyclic citrullinated peptide (CCP) antibodies in juvenile idiopathic arthritis (JIA) have been identified as an important indicator for destructive disease, as is the case with rheumatoid arthritis (RA). Recently, studies have focused on identifying the target proteins of the citrulline modification in both RA and JIA. We found that both IgG anti-citrullinated fibrinogen and α-enolase antibodies were present in our JIA population. In this study, we evaluated serum from patients with various subtypes of JIA to further investigate the presence of isotypes (IgA, IgM) of anti-citrullinated fibrinogen and anti-citrullinated α-enolase, and their association with rheumatoid factor (RF) and anti-CCP antibody isotypes (IgA, IgM, IgG) and other clinical parameters.

Methods:

Sera were obtained from 93 JIA patients, 17 systemic lupus erythematosus (SLE) patients, and 10 healthy children. All sera were measured for antibodies against citrullinated and native fibrinogen and α-enolase IgA and IgM by ELISA. Results were compared to anti-CCP antibody isotypes and RF isotypes, in addition to previously measured IgG anti-citrullinated fibrinogen and α-enolase antibodies. All results were also correlated with various clinical parameters.

Results: 

IgA anti-citrullinated α-enolase antibodies were positive in 14, IgG in 9, and IgM in 11 JIA patients. IgA anti-citrullinated fibrinogen antibodies were positive in 16, IgG in 31, and IgM in 17 JIA patients. Overall, the isotypes of anti-citrullinated fibrinogen and α-enolase appeared more frequently in the polyarticular subset of JIA. One IgM RF-positive polyarticular JIA patient was positive for all 3 isotypes of anti-citrullinated fibrinogen antibodies. IgM anti-citrullinated α-enolase antibodies correlated significantly with IgM anti-citrullinated fibrinogen antibodies (r=0.479, p<0.001), and IgM anti-citrullinated α-enolase antibodies correlated significantly with IgM anti-CCP antibodies (p<0.005). IgM anti-citrullinated fibrinogen antibodies correlated significantly with erythrocyte sedimentation rate (p<0.05). IgA anti-citrullinated α-enolase antibodies correlated significantly with IgA anti-citrullinated fibrinogen antibodies (p<0.05). IgA anti-citrullinated α-enolase antibodies also correlated significantly with IgA RF and IgM RF (p<0.05), and IgA anti-citrullinated fibrinogen antibodies correlated significantly with IgA anti-CCP antibodies and IgM RF (p<0.05). No significant differences were noted the levels of citrullinated autoantibody isotypes when comparing patients with and without joint damage.

Conclusion:

Studies have suggested measuring anti-CCP antibody isotypes in both RA and JIA patients, and recent studies have identified target proteins of the citrulline modification. We found that isotypes of both anti-citrullinated fibrinogen and α-enolase antibodies are present in the serum of JIA patients. JIA patients with elevated isotypes of anti-citrullinated fibrinogen and α-enolase antibodies should be evaluated prospectively in comparison with JIA patients who exhibit a less diverse isotype pattern to further determine their role in the pathogenesis of JIA.


Disclosure:

B. Gilliam,
None;

S. Crespo-Pagnussat,
None;

A. K. Chauhan,
None;

T. L. Moore,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/measurement-and-evaluation-of-isotypes-of-anti-citrullinated-fibrinogen-and-anti-citrullinated-alpha-enolase-antibodies-in-juvenile-idiopathic-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology